Publication: Multimodality imaging in cardiomyopathies
dc.contributor.coauthor | Babur Güler G., Gürsoy M.O., Tan Kürklü T.S., Yakar Tülüce S., Karaca Özer P., Karabulut D., Hatipoğlu S., Barutçu A., Kılıçgedik A., Güler A., Uygur B., İzgi C., Yıldız C., Çiçek Yılmaz D., Genç Albayrak D., İnan D., Özpelit E., Eroğlu Büyüköner E., Güçlü E., Vatansever Ağca F., Çağlıyan F., Akyıldız Akçay F., Kahveci G., Çelik H.G., Altun İ., Altun İ., Dinçer İ., Türkmen İ., Ohtaroğlu Tokdil K., Arslan M., Karacan M., Akbulut M., Turan Şerifler N., Tüfekçioğlu O., Seçkin Göbüt Ö., Yıldırımtürk Ö., Acar R.D.,Yöndem S., Sert Şekerci S., Ünlü S., Üstündağ S., Karagöz U., Kumral Z., Bayram Z. | |
dc.contributor.kuauthor | Aytekin, Saide | |
dc.date.accessioned | 2025-03-06T21:00:44Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Cardiomyopathy, which is shortly defined as a disease of the myocardium, has a broad definition that includes many different diagnoses. Recent advances in cardiac imaging techniques, including basic and advanced echocardiography, computed tomography, nuclear medicine, and cardiac magnetic resonance, allow for a more accurate evaluation of volumes and thickness of cardiac chambers, systolic and diastolic function of the ventricules, and tissue structure. Multimodality imaging often provides the first clinical suspicion for specific etiologies, especially when the medical and family history is unclear, by identification of red flags of underlying systemic diseases. In this review, we aimed to evaluate the role of multimodality imaging in diagnosis of cardiomyopathies with key images and discussed the effects of genetics on the diagnostic, prognostic, and therapeutic guidance of cardiomyopathies. | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.publisherscope | National | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.identifier.doi | 10.5543/tkda.2024.13636 | |
dc.identifier.eissn | 1308-4488 | |
dc.identifier.issn | 1016-5169 | |
dc.identifier.quartile | Q4 | |
dc.identifier.scopus | 2-s2.0-85208602945 | |
dc.identifier.uri | https://doi.org/10.5543/tkda.2024.13636 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/27953 | |
dc.identifier.volume | 52 | |
dc.keywords | Lipoprotein (a) | |
dc.keywords | Cardiovascular risk | |
dc.keywords | Atherosclerosis | |
dc.keywords | Dyslipidemia | |
dc.keywords | Public health | |
dc.keywords | Türkiye | |
dc.language.iso | eng | |
dc.publisher | Kare Publishing | |
dc.relation.ispartof | Türk Kardiyoloji Derneği Arşivi | |
dc.subject | Medicine | |
dc.title | Multimodality imaging in cardiomyopathies | |
dc.title.alternative | Kardiyomiyopatilerde multimodalite görüntüleme | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Aytekin, Saide |